Raisio and Dr. Schär signed a strategic alliance

  1. Dr. Schär
  2. News
  3. Raisio and Dr. Schär signed a strategic alliance

Dr. Schär has signed an agreement on a strategic alliance with the Finnish company Raisio.
Raisio is a forerunner in cholesterol-lowering functional foods and an innovative expert in Finnish oats. Combined expertise of the companies opens new commercial opportunities for both.

The long-term framework agreement now signed outlines the essential contents of the strategic alliance. The companies are exploring opportunities for extensive collaboration in product development and manufacturing, among other things.   

Dr. Schär and Raisio see that this strategic alliance creates added value for both companies.
The collaboration also opens new opportunities for Raisio’s Benecol and Elovena brands,
in Dr. Schär’s strong markets, particularly in Germany, Italy, France and Spain.

Dr. Schär’s President Ulrich Ladurner: “The strategic alliance with Raisio is an important step for us as it will enable us to further develop and strengthen our distribution network. In addition, Raisio’s value brands will complete our portfolio and we will get access to Raisio’s excellence in oats. As a family-owned company, it is important for us to know that the companies share the same core values.”

Raisio’s President and CEO Pekka Kuusniemi: “With its clear focus and high expertise in the markets of value-added products, Dr. Schär is an excellent partner for Raisio. Dr. Schär’s strong foothold in Europe complements Raisio’s geographical presence.”

Raisio is an international company specialised in healthy, responsibly produced food and fish feeds. Well-known brands include Benecol, Elovena, Sunnuntai, Torino and Benella. In Raisio’s products, the focus is on well-being, health, good taste and sustainable development. Profitable growth is ensured through strong expertise and passion for creating new. Raisio’s shares are listed on Nasdaq Helsinki Ltd. In 2017, the Group’s net sales for continuing operations totalled EUR 228 million.